Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik J Scheper

Showing results (101-110 of 177) with videos related to

Pageof 18
Sort By:
Oncoimmunology|August 31, 2012
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibitionDinja Oosterhoff, Sinéad Lougheed, Rieneke van de Ven, et al.
Molecular and Cellular Biology|August 18, 2004
Mrp4 confers resistance to topotecan and protects the brain from chemotherapyMarkos Leggas, Masashi Adachi, George L Scheffer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line modelSaskia J A M Santegoets, Hetty J Bontkes, Anita G M Stam, et al.
Blood|May 25, 2006
Evidence for subcomplexes in the Fanconi anemia pathwayAnnette L Medhurst, El Houari Laghmani, Jurgen Steltenpool, et al.
The American Journal of Pathology|July 11, 2002
Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cellsRonald J C L M Vuylsteke, Paul A M van Leeuwen, Sybren Meijer, et al.
Immunology Letters|May 2, 2009
Unimpaired immune functions in the absence of Mrp4 (Abcc4)Rieneke van de Ven, Jan de Groot, Anneke W Reurs, et al.
Clinical Immunology (Orlando, Fla.)|November 30, 2011
Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-αFamke L Schneiders, Renée C G de Bruin, Saskia J A M Santegoets, et al.
Journal for Immunotherapy of Cancer|July 22, 2015
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumabSaskia Jam Santegoets, Anita Gm Stam, Sinéad M Lougheed, et al.
International Journal of Cancer|June 22, 2007
CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasiaJohan W Molling, Tanja D de Gruijl, Judith Glim, et al.
The Journal of General Virology|September 29, 1999
Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasiaHetty J Bontkes, Tanja D de Gruijl, Astrid Bijl, et al.
Pageof 18

Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Oncoimmunology|August 31, 2012
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibitionDinja Oosterhoff, Sinéad Lougheed, Rieneke van de Ven, et al.
Molecular and Cellular Biology|August 18, 2004
Mrp4 confers resistance to topotecan and protects the brain from chemotherapyMarkos Leggas, Masashi Adachi, George L Scheffer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line modelSaskia J A M Santegoets, Hetty J Bontkes, Anita G M Stam, et al.
Blood|May 25, 2006
Evidence for subcomplexes in the Fanconi anemia pathwayAnnette L Medhurst, El Houari Laghmani, Jurgen Steltenpool, et al.
The American Journal of Pathology|July 11, 2002
Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cellsRonald J C L M Vuylsteke, Paul A M van Leeuwen, Sybren Meijer, et al.
Immunology Letters|May 2, 2009
Unimpaired immune functions in the absence of Mrp4 (Abcc4)Rieneke van de Ven, Jan de Groot, Anneke W Reurs, et al.
Clinical Immunology (Orlando, Fla.)|November 30, 2011
Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-αFamke L Schneiders, Renée C G de Bruin, Saskia J A M Santegoets, et al.
Journal for Immunotherapy of Cancer|July 22, 2015
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumabSaskia Jam Santegoets, Anita Gm Stam, Sinéad M Lougheed, et al.
International Journal of Cancer|June 22, 2007
CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasiaJohan W Molling, Tanja D de Gruijl, Judith Glim, et al.
The Journal of General Virology|September 29, 1999
Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasiaHetty J Bontkes, Tanja D de Gruijl, Astrid Bijl, et al.
Pageof 18